Switch to:
More From Other Websites
The Scariest Prescription Drug Price Chart You'll Ever See Apr 23 2017
Why Now Is Not the Time to Buy Valeant Pharmaceuticals Apr 22 2017
Valeant Shares Plummet as Debt Issues Remain Unsolved, Prices New Psoriasis Drug Apr 21 2017
Why Valeant Pharmaceuticals, Manhattan Associates, and NCR Slumped Today Apr 21 2017
1 Current and 1 Former Healthcare CEO Who Deserve Far More Flak Than United Airlines' Oscar... Apr 21 2017
Valeant Pharmaceuticals: Not Worth the Risk! Apr 21 2017
Jim Cramer -- Valeant's Not Worth the Speculation Apr 21 2017
Valeant prices psoriasis treatment at $3,500 per month Apr 21 2017
Valeant says its plaque psoriasis drug will cost $3,500 a month Apr 21 2017
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The... Apr 21 2017
Valeant: Will Earnings Even Matter? Apr 20 2017
4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings Apr 20 2017
Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals Apr 19 2017
[$$] Investors bet on Incyte drug success Apr 19 2017
How Drug-Company 'Benevolence' Silences the Sick Apr 18 2017
Valeant Pharmaceuticals' Market Cap Is Now Lower Than Its Projected Full-Year EBITDA Apr 13 2017
Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial... Apr 10 2017
Takeaways and Observations; Play a Tesla Tune: Doug Kass' Views Apr 10 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK